Elevated AKT occurs in ∼50% of all human cancers including prostate cancer (CaP) [5], [6] and its activation is subject to negative regulation by tumor suppressor phosphatase and tensin homolog (PTEN) [5], [7]. This evidence concerns the gene AKT1 and cancer.